https://adisinsight.springer.com/trials/700058263?error=cookies_not_supported&code=57f62898-039e-4b44-827e-1751ce795acf
A Phase 2 Efficacy, Safety and Pharmacokinetic Study of XP21279 BL2 and Sinemet in Parkinson's...
This trial compared the efficacy and tolerability of carbidopa/XP 21279 and levodopa/carbidopa [Sinemet] in patients with Parkinson's disease and motor